KELOWNA, BC, Jan. 31, 2022 /PRNewswire/ – The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the “Company” or “The Valens Company” or “Valens”), a leading manufacturer of cannabis products, is pleased to announce that it will host a virtual Investor Day on February 7, 2022, at 11:00 AM ET. Registration for the webcast will start at 10:45 AM ET and the presentation will begin at 11:00 AM ET.
Valens executive management team will discuss 2022 corporate initiatives including recent developments, financial objectives, acquisition updates, and will provide insights into the Company’s operations followed by a Q&A session. Investors who are interested in attending the event should register via the link provided below. For investors that would like to ask questions on the call, please email your questions to ir@thevalenscompany.com twenty-four hours prior to the call.
DATE: February 7, 2022
TIME: 11:00 AM ET
REGISTRATION LINK: https://bit.ly/3G3US69
Q&A EMAIL: ir@thevalenscompany.com
PARTICIPANT DIAL-IN: Toll Free – 1-877-407-0792 or Toll/International – 1-201-689-8263
If attendees are not able to join the live event, an archived webcast will also be made available after the event has concluded on the Company’s website at https://thevalenscompany.com/investors/.
At Valens, it’s Personal.
About The Valens Company
The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company provides proprietary cannabis processing services, in addition to best-in-class product development, manufacturing, and commercialization of cannabis consumer packaged goods. The Valens Company’s high-quality products are formulated for the medical, health and wellness, and recreational consumer segments, and are offered across all cannabis product categories with a focus on quality and innovation. The Company also manufactures, distributes, and sells a wide range of CBD products in the United States through its subsidiary Green Roads, and distributes medicinal cannabis products to Australia through its subsidiary Valens Australia. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, the Company continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences in key markets. Through Valens Labs, the Company is setting the standard in cannabis testing and research and development with Canada’s only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific. Discover more on The Valens Company at http://www.thevalenscompany.com.
